Gynaecology Injections
Advanced Injectable Therapies for Women's Reproductive Health
Carygest 250 mg Inj
Carygest 250 mg Injection is a progesterone-based injectable medication widely used in gynecology and reproductive medicine. It plays a vital role in supporting early pregnancy by preparing the uterine lining for implantation. This formulation is especially beneficial in cases of recurrent miscarriages, luteal phase defects, and infertility management. Doctors frequently prescribe it as part of assisted reproductive techniques such as IVF. In addition to pregnancy support, Carygest 250 mg helps regulate menstrual disorders and provides symptomatic relief in cases of hormonal imbalance, making it an indispensable therapy in women's reproductive care.
Carygest 500 mg Inj
Carygest 500 mg Injection is a high-dose progesterone preparation used for more intensive hormonal support in women with advanced reproductive needs. It is indicated in cases where higher levels of progesterone are required to sustain pregnancy. This injection is particularly important in patients undergoing in vitro fertilization (IVF) or other assisted reproductive technologies. The increased dosage ensures stronger endometrial support, which is critical for successful embryo implantation. Carygest 500 mg also contributes to stabilizing the uterine environment, reducing the risk of miscarriage, and improving pregnancy outcomes in high-risk patients. Its clinical reliability makes it a preferred choice among gynecologists worldwide.